<DOC>
	<DOC>NCT02901366</DOC>
	<brief_summary>To assess the plasma pharmacokinetics, the routes extent of elimination, and the metabolites of FYU-981 after a single 1 mg oral dose of 14C-FYU-981 in healthy male subjects.</brief_summary>
	<brief_title>Mass Balance Study of FYU-981</brief_title>
	<detailed_description />
	<criteria>Japanese healthy adult subjects Body mass index: &gt;=18.5 and &lt;25.0 Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study Have participated in a [14C]study within the last 12 months prior to dosing of the investigational drug Exposure to radiation for therapeutic or diagnostic reasons (except dental Xrays and plain Xrays of thorax and bony skeleton) within the last 12 months prior to dosing of the investigational drug Occupationally exposed worker</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Mass balance</keyword>
</DOC>